awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26786766-20EF9A4C-EC5F-4E5B-9BED-7F44B404A506
Q26786766-20EF9A4C-EC5F-4E5B-9BED-7F44B404A506
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786766-20EF9A4C-EC5F-4E5B-9BED-7F44B404A506
Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
P2860
Q26786766-20EF9A4C-EC5F-4E5B-9BED-7F44B404A506
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786766-20EF9A4C-EC5F-4E5B-9BED-7F44B404A506
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cb8c589e1a7e7efa12179a962a7dfde00cf8d1bf
P2860
Efficacy and adverse events of aflibercept, ranibizumab and bevacizumab in age-related macular degeneration: a trade-off analysis.